Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
European Journal of Pharmacology|November 2, 2025
GPCR signaling from endosome: mechanistic insights and therapeutic potentialsLi Chen, Canquan Mao, Yuhong JiangCurrent Pharmaceutical Design|March 6, 2020
G Protein-coupled Receptors in Cancer Stem CellsYuhong Jiang, Xin Zhuo, Canquan MaoFrontiers in Immunology|June 20, 2025
Dissecting the multi-omics landscape of TEAD1 in hepatocellular carcinoma: cycle regulation and metastatic potentialRuiping Huai, Canquan Mao, Lili XiongActa Pharmaceutica Sinica. B|June 9, 2025
Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and functionYuhong Jiang, Shanshan Qi, Canquan MaoACS Nano|November 3, 2023
The Distinct Properties of Polysaccharide Nanoparticles Tune Immune Responses against mRNA Antigen via Stimulator of Interferon Genes-Mediated Autophagy and InflammasomeYue Wu, Xiaoyu Liang, Canquan Mao, et al.Computers in Biology and Medicine|August 13, 2013
Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental dataLili Xiong, Wei Jiang, Rui Zhou, et al.Small (Weinheim an Der Bergstrasse, Germany)|December 2, 2024
Dual-functional Nanosized Albumin Facilitates CRISPR-Cas9-PAR2 to Mitigate Cytokine Storm via TLR4 and Pyroptosis SignalingJianbin Li, Dongmei Zheng, Shanshan Qi, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|October 2, 2021
PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expressionYuhong Jiang, Xin Zhuo, Yue Wu, et al.Frontiers in Pharmacology|May 10, 2021
Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR TransactivationYuhong Jiang, Xin Zhuo, Xiujuan Fu, et al.Biochemical Pharmacology|March 27, 2026
Deciphering the immunomodulatory code: how metal nanoadjuvants orchestrate intracellular immune signaling cascadesLirong Fang, Yiting Zhao, Jieling Zhao, et al.Pageof 4